Physical Address

304 North Cardinal St.
Dorchester Center, MA 02124

The start of sales of sales craws craws $ 22 m

Cancer has one of the superior provisions of death in the whole world. The National Cancer Institute reported almost 20 million cancer cases and 9.7 millions of the 2022’s cancer dead of the 2022, with projects that show a rise of 2040.

CRAZSpotted from nagoye University in Japan in 2018, use Mastray (Mirra) Detervation of the X $ in the US and Bolster market on the US and Bolster its R & D

Ryuinids Onose, CO-founder and CEO of CEO to an arravant that the company has finished his series c funding on a $ 100 billion under $ 100 billion.

X & kskAn exit investor, I have estest the most total of $ 47 million, the first investment in a Japanese house group, Daiwa’s bank group and aowa

The CRAF trip started when I come in the way of the cancer trick affected his family, with their grandparents are diagnosed with illness. These personal experiences inspired a strong commitment to help address the cancer issue. Honelo and Takao Yasui, a teacher associated with Nagoya, Co-founded only one month after they met. Yasui created a new method for the earlier cancer detection using urinarily biomarkers.

Initial detection of a treatment condition can be challenged traditional diagnostic methods such as blood tests can be invasive, let’s go to dinerous. In addition has limited access to medical installations in certain areas that make challenge for the individuals to get easily try to cancer, accordingly.

CRAF has diolescents of addressing these gaps that provides unicleading urine that allows the first relevation of cancer, even at a fae a lot, as in the stage 1.

“The test can be conducted by the house of a patient’s house and is fueled by Amonic Micories, doing the first more accessible and effected,” honest, “held. “Our users are conscious health individuals that are concerned with cancer but finds challenge to the conventional screenings for time, cost limitations.”

Several Startups are creating platforms for the early cancer detection in the industry, as GRAIL, Freenome, Dizzles diagnostic deli and it Hi health. I am

CRAF DIFFERARY HEARS WITH MICRADUE A Biomarker instead of CfDna (DNA of Cell-Free) as most competitors and using urine.

“Mirna, that acquired the raised recognition after being related to the 2024 Nobel awardis known for their deep participation in the scar of the scar of, hones explained. ” The honest is proactively the claim cells.

Another one unique aspect of their product is the use of urine. Onose said urine is easy and not invasive, provide many scientific and practical benefits. It has a few impurities that other beams, make the biomark seats that is better, it’s added. This helps to decrease any measurement error, as those of hemolisi in blood and saves money on the tests.

The first CRAF product, Misber, a test of seven different conventions (pancre, generarian, farmings and welfare senses, according to the complaints of revenue, according to CEO’s company.

“We’ve been following more than 1000 Medical institutions and about 600 Pharmacies in Japan, serve about 20,000 users. Our dedicated dedicates. Our fingers tagcray.

The admission model offers the use packages and the underline packages for the regular test, with multiple opting users for submission plans. Published $ 5 million in the income in 2024 and the purpose of generate $ 15 million at the end of this year, hello told Techcrunnch.

Craig intends to extend the scope of masterpiece to include more than ten different types of cancer in the coming year. In addition, the initop is prepared to their technology for initial detection of non-cancerious diseases, as a neurodiary disorders as dementia.

CRAF has UR LABOR & D in Irvine, California, and plan to open another office in San Diego to manage their business operations.

The new funding will help the consignment of the US market with their mixture to complete the trials in the United States in 2026-End and get the fed approval as 2027.

It has already started collecting pancreatal cancer samples in the collaboration with 30 medical institutions through 15 US United States.

Source link